Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-01-10 Sale |
2022-01-11 6:54 pm |
Catalent Inc. | CTLT | Flynn Karen Chief Commercial Officer |
2,472 | $116.64 | $288,334 | 33,223 (Direct) |
View |
2021-01-11 Sale |
2021-01-11 7:12 pm |
Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO |
2,478 | $112.3 | $278,279 | 34,544 (Direct) |
View |
2021-01-04 Sale |
2021-01-05 9:44 pm |
Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO |
99 | $104.42 | $10,338 | 37,022 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 5:48 pm |
2025-12-31 2035-01-02 |
Quanterix Corp | QTRX | Flynn Karen Director |
23,256 | $0 | 49,661 (Direct) |
View |
2024-05-24 Option Award |
2024-05-29 4:55 pm |
N/A N/A |
Sotera Health Co | SHC | Flynn Karen Director |
20,089 | $0 | 20,089 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 4:09 pm |
2024-12-31 2034-01-02 |
Quanterix Corp | QTRX | Flynn Karen Director |
9,359 | $0 | 32,817 (Direct) |
View |
2023-10-27 Option Award |
2023-10-31 5:00 pm |
N/A N/A |
Catalent Inc. | CTLT | Flynn Karen Director |
6,993 | $0 | 24,339 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:03 pm |
N/A N/A |
Quanterix Corp | QTRX | Flynn Karen Director |
918 | $12.86 | 35,582 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:03 pm |
2023-12-31 2033-01-03 |
Quanterix Corp | QTRX | Flynn Karen Director |
20,207 | $0 | 35,582 (Direct) |
View |
2022-10-27 Option Award |
2022-10-31 4:49 pm |
N/A N/A |
Catalent Inc. | CTLT | Flynn Karen Director |
4,149 | $0 | 17,346 (Direct) |
View |
2022-10-03 Option Award |
2022-10-05 4:04 pm |
N/A N/A |
Quanterix Corp | QTRX | Flynn Karen Director |
1,066 | $10.48 | 14,457 (Direct) |
View |
2022-09-15 Option Award |
2022-09-19 2:31 pm |
N/A N/A |
Catalent Inc. | CTLT | Flynn Karen Director |
245 | $0 | 13,197 (Direct) |
View |
Ownership |
2022-09-19 2:15 pm |
N/A N/A |
Catalent Inc. | CTLT | Flynn Karen Director |
0 | $0 | 18,442 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 4:07 pm |
N/A N/A |
Quanterix Corp | QTRX | Flynn Karen Director |
164 | $16.79 | 13,391 (Direct) |
View |
2022-06-06 Option Award |
2022-06-14 12:09 pm |
N/A 2032-06-06 |
Quanterix Corp | QTRX | Flynn Karen Director |
33,068 | $0 | 33,068 (Direct) |
View |
2021-07-26 Option Award |
2021-07-28 4:26 pm |
N/A 2031-07-26 |
Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO |
7,104 | $0 | 41,648 (Direct) |
View |
2020-07-30 Option Award |
2020-08-03 09:03 am |
N/A 2030-07-30 |
Catalent Inc. | CTLT | Flynn Karen Pres. Biologics & CCO |
9,481 | $0 | 45,126 (Direct) |
View |